IE 11 is not supported. For an optimal experience visit our site on another browser.

InfuSystem Holdings Announces Expiration of Warrants

MADISON HEIGHTS, Mich., April 12, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services in the U.S. and Canada has announced today that all 9,472,496 outstanding warrants to acquire shares of its common stock have expired in accordance with their terms on April 11, 2011 and are no longer outstanding. The warrants had been issued in connection with the Company's initial public offering of common stock units (and in certain private placements in the year after the initial public offering). As of April 12, 2011, the Company's capital structure consists of 21,056,133 shares of Common Stock issued and outstanding.
/ Source: GlobeNewswire

MADISON HEIGHTS, Mich., April 12, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services in the U.S. and Canada has announced today that all 9,472,496 outstanding warrants to acquire shares of its common stock have expired in accordance with their terms on April 11, 2011 and are no longer outstanding. The warrants had been issued in connection with the Company's initial public offering of common stock units (and in certain private placements in the year after the initial public offering). As of April 12, 2011, the Company's capital structure consists of 21,056,133 shares of Common Stock issued and outstanding.

InfuSystem is a leading provider of ambulatory infusion pumps to the outpatient oncology market as well as new and pre-owned infusion pumps and other biomedical equipment, and biomedical recertification, maintenance and repair services to hospitals, oncology practices and other alternate site health care providers. Headquartered in Madison Heights, Michigan, InfuSystem delivers local, field-based customer support and operates Biomedical Service Centers of Excellence in Kansas City, Los Angeles and Toronto.

CONTACT: Investor Contact: Pat LaVecchia info@infusystem.com Tel: (800) 962-9656 Media Contact: David Haar info@infusystem.com Tel: (800) 962-9656